BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24246525)

  • 41. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
    Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
    Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Contraception for women over 40].
    Erny R; Mathet M
    Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?
    Merki-Feld GS; Bitzer J
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):213-220. PubMed ID: 32336145
    [No Abstract]   [Full Text] [Related]  

  • 44. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).
    Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Sandset PM; Martelletti P;
    J Headache Pain; 2017 Oct; 18(1):108. PubMed ID: 29086160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal contraception and risk of cardiovascular disease. An international perspective.
    Farley TM; Collins J; Schlesselman JJ
    Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.
    Lalude OO
    Curr Cardiol Rep; 2013 Jul; 15(7):374. PubMed ID: 23715878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evidence-based approach to hormonal contraception and headaches.
    Harris M; Kaneshiro B
    Contraception; 2009 Nov; 80(5):417-21. PubMed ID: 19835714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
    Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
    Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral contraception reviewed.
    Elstein M
    IPPF Med Bull; 1979 Jun; 13(3):1-2. PubMed ID: 12335871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of combined hormonal contraceptives on vessels functionality.
    Rabiolo A; Corvi F; Monteduro D; Benatti L; Cicinelli MV; Fogliato G; Querques G; Bandello F
    Arch Gynecol Obstet; 2016 Nov; 294(6):1317-1322. PubMed ID: 27501928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complications and contraindications of oral contraception.
    Beck WW
    Clin Obstet Gynecol; 1981 Sep; 24(3):893-901. PubMed ID: 7026110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study.
    Assiri GA; Bannan DF; Alshehri GH; Alshyhani M; Almatri W; Mahmoud MA
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contraception for the transitional years of women older than 40 years of age.
    Upton GV; Corbin A
    Clin Obstet Gynecol; 1992 Dec; 35(4):855-64. PubMed ID: 1451368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives.
    Briggs PE; Praet CA; Humphreys SC; Zhao C
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):190-6. PubMed ID: 23299629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined hormonal contraception and its effects on mood: a critical review.
    Schaffir J; Worly BL; Gur TL
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):347-55. PubMed ID: 27636867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.
    Bergendal A; Persson I; Odeberg J; Sundström A; Holmström M; Schulman S; Björgell O; Kieler H
    Obstet Gynecol; 2014 Sep; 124(3):600-609. PubMed ID: 25162263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.